TY - JOUR T1 - Effect of Albumin on the Estimation, <em>In Vitro</em>, of Phenytoin V<sub>max</sub> and <em>K</em> <sub>m</sub> Values: Implications for Clinical Correlation JF - Journal of Pharmacology and Experimental Therapeutics JO - J Pharmacol Exp Ther SP - 391 LP - 396 VL - 282 IS - 1 AU - Linda K. Ludden AU - Thomas M. Ludden AU - Jerry M. Collins AU - Helen S. Pentikis AU - John M. Strong Y1 - 1997/07/01 UR - http://jpet.aspetjournals.org/content/282/1/391.abstract N2 - The effect of bovine serum albumin (BSA) on human liver metabolism,in vitro, of 14C-phenytoin (PHT) was studied. Michaelis Menten parameters were determined for the conversion of PHT to p-hydroxy phenytoin in seven different microsomal preparations with the addition of 0, 2, and 4% BSA. The unboundK m(K m u) values were 30.8 ± 18.6, 1.57 ± 0.21 and 1.50 ± 0.17 μM (mean ± S.D.), respectively; however, there was excellent agreement among the Vmax values (29.1, 31.8 and 31.5 pmol/min/mg). With intact tissue slices, BSA (4%) added to incubations of PHT had a minimal effect on the Vmax values in two of the four livers studied and resulted in a mean K m u value of 2.20 ± 0.59 μM, although theK m u in the absence of BSA was 6.64 ± 3.17. In scaling-up to the whole body, Vmaxvalues were 3.9 and 1.0 mg/kg/day for microsomes and slices, respectively, compared to 5.9 mg/kg/day, in vivo. TheK m u values determined in the presence of albumin in both microsomes and slices were similar to those based on in vivo human steady state data (K m u = 2-3 μM), and the intersubject variation, in vitro, was decreased in the presence of BSA. These findings for phenytoin metabolism suggest that the addition of albumin to incubation media for slices or microsome experiments may yield K m estimates that are more representative of in vivo values. The American Society for Pharmacology and Experimental Therapeutics ER -